Class III
Terminated
Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only. GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108.
Why: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
- Company
- GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Aiken, SC, United States - Reported
- Apr 30, 2014
- Recall started
- Feb 20, 2014
- Ended
- Jan 20, 2017
- Where sold
- U.S. Nationwide
- Amount
- 150 cases
- Full product description
- Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mg Patches. OTC Only. GlaxoSmithKlein, 1000 GSK Drive, Moon Township, PA 15108. UPC: 0-03-0766-1480-30-2.
- Lots / codes affected
- Lot #13L05N, Expiry: 8/15
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.